Allakos Inc (ALLK)
1.035
-0.02
(-1.43%)
USD |
NASDAQ |
Apr 18, 09:57
Allakos Cash from Operations (TTM): -116.48M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -116.48M |
| September 30, 2023 | -139.00M |
| June 30, 2023 | -135.65M |
| March 31, 2023 | -135.82M |
| December 31, 2022 | -279.97M |
| September 30, 2022 | -298.56M |
| June 30, 2022 | -318.87M |
| March 31, 2022 | -335.88M |
| December 31, 2021 | -207.85M |
| September 30, 2021 | -176.89M |
| June 30, 2021 | -166.28M |
| March 31, 2021 | -141.57M |
| December 31, 2020 | -113.92M |
| Date | Value |
|---|---|
| September 30, 2020 | -98.62M |
| June 30, 2020 | -79.00M |
| March 31, 2020 | -68.35M |
| December 31, 2019 | -63.01M |
| September 30, 2019 | -56.55M |
| June 30, 2019 | -48.70M |
| March 31, 2019 | -42.39M |
| December 31, 2018 | -38.45M |
| September 30, 2018 | -33.32M |
| June 30, 2018 | -30.00M |
| March 31, 2018 | -26.47M |
| December 31, 2017 | -22.57M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-335.88M
Minimum
Mar 2022
-48.70M
Maximum
Jun 2019
-156.89M
Average
-135.82M
Median
Mar 2023
Cash from Operations (TTM) Benchmarks
| Vertex Pharmaceuticals Inc | 3.537B |
| Sarepta Therapeutics Inc | -500.99M |
| CytomX Therapeutics Inc | -56.04M |
| Myomo Inc | -6.173M |
| Acurx Pharmaceuticals Inc | -9.801M |